查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790211

美国小分子药物研发外包市场规模、份额和趋势分析报告：按工作流程、服务、治疗领域、最终用途和细分市场预测，2025 年至 2033 年

U.S. Small Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国小分子药物研发外包市场概况

美国小分子药物研发外包市场规模预计在 2024 年为 15.2 亿美元，预计到 2033 年将达到 34.7 亿美元，2025 年至 2033 年的复合年增长率为 9.7%。市场受到研发支出增加、对早期研究活动的日益关注以及内部资源有限的生物技术公司的成长的推动。

此外，外包已成为製药和生物技术公司的策略选择，这些公司希望加快进度，降低固定间接成本，并在药物化学、先导药物最适化、ADME/PK 测试和 IND 授予活动等领域获得专业知识。

人工智慧化合物设计、基于 CRISPR 的标靶验证、高性能筛检和 3D 细胞模型等创新技术正在改变药物研发流程，委外研发机构(CRO) 能够提供更有效率、更可预测的成果。此外，研发成本的上升、药物开发需求的增加以及向虚拟製药模式的转变也为市场提供了支撑。此外，註册临床试验的增加、小分子药物核准率的提高、医疗技术的进步、正在研究的疾病数量的增加以及对新疗法的迫切需求预计将推动市场发展。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国小分子药物发现外包市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验量分析（2024年）
    • 各国临床试验总数
    • 各阶段临床试验总数
    • 按研究设计分類的临床试验总数
    • 按主要治疗领域分類的临床试验总数
  • 定价模式分析
  • 科技
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析

第四章美国小分子药物研发外包市场：工作流程估算与趋势分析

  • 美国小分子药物研发外包市场（依工作流程）：细分仪表板
  • 美国小分子药物研发外包市场（依工作流程）：差异分析
  • 按工作流程，2021-2033 年
  • 目标识别与筛检
  • 对象检验和功能资讯科学
  • 潜在客户资格审查和候选人优化
  • 临床前开发
  • 其他的

第五章美国小分子药物研发外包市场：按服务分類的估价与趋势分析

  • 美国小分子药物研发外包市场（按服务）：细分仪表板
  • 美国小分子药物研发外包市场（按服务）：波动分析
  • 按服务划分，2021-2033 年
  • 化学服务
  • 生物服务

第六章：美国小分子药物研发外包市场（依治疗领域、估价与趋势分析）

  • 美国小分子药物研发外包市场（依治疗领域）：细分仪表板
  • 美国小分子药物研发外包市场（依治疗领域）：波动分析
  • 依治疗领域，2021-2033年
  • 呼吸系统
  • 疼痛和麻醉
  • 肿瘤学
  • 眼科
  • 血液学
  • 心血管系统
  • 内分泌
  • 胃肠道
  • 免疫调节
  • 抗感染
  • 中枢神经系统
  • 皮肤科
  • 泌尿生殖系统

第七章美国小分子药物研发外包市场：依最终用途的估计与趋势分析

  • 美国小分子药物研发外包市场（依最终用途）：细分仪表板
  • 美国小分子药物研发外包市场（依最终用途）：波动分析
  • 按应用，2021-2033 年
  • 製药和生物技术公司
  • 学术机构

第八章 竞争态势

  • 市场参与企业分类
    • 市场领导者
    • 新参与企业
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Charles River Laboratories
    • Laboratory Corporation of America Holdings（Covance）
    • Albany Molecular Research（Curia）
    • Merck & Co., Inc.
    • QIAGEN
    • Eurofins
    • Evotec
    • GenScript BIoTech
    • Pharmaron
    • Syngene International
    • Dalton Pharma Services
    • Oncodesign
    • Jubilant Biosys
    • Domainex
    • Dr. Reddy Laboratories Ltd.
    • Pharmaron Beijing Co., Ltd.
    • TCG Lifesciences Pvt Ltd.

第九章 主要建议

Product Code: GVR-4-68040-687-1

U.S. Small Molecule Drug Discovery Outsourcing Market Summary

The U.S. small molecule drug discovery outsourcing market size was estimated at USD 1.52 billion in 2024 and is projected to reach USD 3.47 billion by 2033, growing at a CAGR of 9.7% from 2025 to 2033. Increasing R&D expenses, rising focus on early-stage research activities, and growing biotech companies with limited in-house resources drive the market.

Besides, outsourcing has emerged as a strategic option for pharmaceutical and biotech companies aiming to accelerate the timelines, lower fixed overhead costs, and gain access to specialized expertise in areas such as medicinal chemistry, hit-to-lead optimization, ADME/PK studies, and IND-enabling activities.

Innovations like AI-driven compound design, CRISPR-based target validation, high-throughput screening, and 3D cell models transform discovery processes, enabling contract research organizations (CROs) to provide more efficient and predictive results. Furthermore, rising R&D costs, increased demand for drug development, and a shift towards virtual pharmaceutical models support the market. In addition, an increase in registered clinical studies, a higher approval rate for small molecule drugs, advancements in medical technology, a rise in diseases being studied, and the urgent need for new treatments are anticipated to drive the market.

U.S. Small Molecule Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. small molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, and end use:

  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Service
    • 1.2.3. Therapeutics Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain-based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Small Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for outsourcing services in drug development
      • 3.2.1.2. Technological advancements in drug discovery
      • 3.2.1.3. Rising shortening time-to-market pressures
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Intellectual property (IP) and data security concerns
      • 3.2.2.2. Limited standardization and reproducibility
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Country
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. U.S. Small Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2021 - 2033 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Small Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 5.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 5.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 5.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 5.4. Chemistry Services
    • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Biology Services
    • 5.5.1. Biology Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Small Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 6.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2021 - 2033 (USD Million)
  • 6.4. Respiratory system
    • 6.4.1. Respiratory System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pain and Anesthesia
    • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ophthalmology
    • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Hematology
    • 6.8.1. Hematology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Endocrine
    • 6.10.1. Endocrine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.11. Gastrointestinal
    • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.12. Immunomodulation
    • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.13. Anti-infective
    • 6.13.1. Anti-infective Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.14. Central Nervous System
    • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.15. Dermatology
    • 6.15.1. Dermatology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.16. Genitourinary System
    • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Small Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. U.S. Small Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. U.S. Small Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 7.3. U.S. Small Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology companies
    • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Academic Institutes
    • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. Charles River Laboratories
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Laboratory Corporation of America Holdings (Covance)
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Albany Molecular Research (Curia)
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Merck & Co., Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. QIAGEN
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Eurofins
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Evotec
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. GenScript Biotech
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Pharmaron
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Syngene International
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Dalton Pharma Services
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Oncodesign
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Jubilant Biosys
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Domainex
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Service Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Dr. Reddy Laboratories Ltd.
      • 8.3.15.1. Company Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Service Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. Pharmaron Beijing Co., Ltd.
      • 8.3.16.1. Company Overview
      • 8.3.16.2. Financial Performance
      • 8.3.16.3. Service Benchmarking
      • 8.3.16.4. Strategic Initiatives
    • 8.3.17. TCG Lifesciences Pvt Ltd.
      • 8.3.17.1. Company Overview
      • 8.3.17.2. Financial Performance
      • 8.3.17.3. Service Benchmarking
      • 8.3.17.4. Strategic Initiatives

Chapter 9. Key Recommendations

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2021 - 2033 (USD Million)
  • Table 5 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 6 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2021 - 2033 (USD Million)
  • Table 7 U.S. Small Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 U.S. small molecule drug discovery outsourcing market dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. Small molecule drug discovery outsourcing market: workflow outlook and key takeaways
  • Fig. 20 U.S. small molecule drug discovery outsourcing market: workflow movement analysis
  • Fig. 21 Target identification & screening market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Target validation & functional informatics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Lead identification & candidate optimization market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Preclinical development market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. small molecule drug discovery outsourcing market: Service outlook and key takeaways
  • Fig. 27 U.S. small molecule drug discovery outsourcing market: Service movement analysis
  • Fig. 28 Chemistry services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Biology services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. small molecule drug discovery outsourcing market: therapeutics area outlook and key takeaways
  • Fig. 31 U.S. small molecule drug discovery outsourcing market: therapeutics area movement analysis
  • Fig. 32 Respiratory system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Pain and anesthesia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Ophthalmology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Hematology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cardiovascular market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Endocrine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Gastrointestinal market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Immunomodulation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Anti-infective market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Central nervous system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Dermatology market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Genitourinary system market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. small molecule drug discovery outsourcing market: End use outlook and key takeaways
  • Fig. 46 U.S. small molecule drug discovery outsourcing market: End use movement analysis
  • Fig. 47 Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key company categorization
  • Fig. 50 Service heat map analysis
  • Fig. 51 Strategic framework